Insomnia treatment that addresses why you cannot sleep — not just whether you can.
Chronic insomnia is one of the most prevalent and most undertreated conditions in psychiatric practice. At Wave Psychiatric Group, our board-certified psychiatrists treat insomnia with the clinical depth it deserves — addressing it as both a standalone condition and as a central feature of the psychiatric presentations it so frequently accompanies.
Understanding insomnia
Insomnia is defined as persistent difficulty initiating or maintaining sleep, or early morning awakening with inability to return to sleep, occurring at least three nights per week for at least three months, despite adequate opportunity for sleep, and causing meaningful daytime impairment. It is not simply sleeping less than a recommended number of hours. It is a clinical condition characterized by the subjective experience of poor sleep quality or insufficient sleep, accompanied by functional consequences — fatigue, cognitive impairment, mood disturbance, reduced performance, and a pervasive sense of daytime dysfunction — that erode quality of life in ways that accumulate over time.
Chronic insomnia affects a substantial proportion of the adult population and is considerably more than an inconvenience. The consequences of prolonged sleep disruption extend well beyond tiredness. Sleep is the period during which memory consolidation, emotional processing, immune regulation, metabolic restoration, and neural repair occur. Chronic sleep deprivation disrupts all of these processes — impairing cognitive function, amplifying emotional reactivity, dysregulating stress response systems, increasing inflammatory burden, and substantially worsening the course of virtually every psychiatric condition it accompanies.
Understanding insomnia well requires understanding why it persists. The 3P model — predisposing, precipitating, and perpetuating factors — is the most clinically useful framework. Predisposing factors include biological and psychological traits that create vulnerability to insomnia — hyperarousal of the nervous system, a tendency toward ruminative thinking, and anxiety sensitivity. Precipitating factors are the events or circumstances that trigger an acute episode of poor sleep — stress, illness, loss, a change in schedule or environment. Perpetuating factors are the behaviors and thought patterns that transform acute sleep disruption into a chronic condition — irregular sleep schedules, extended time in bed, daytime napping, clock-watching, and the development of conditioned arousal in the sleep environment, in which the bed itself becomes associated with wakefulness and anxiety rather than sleep.
This last category — the perpetuating factors — is the primary target of the most effective treatment for chronic insomnia. And it is why a prescription alone rarely produces durable improvement.
Insomnia and psychiatric illness — a bidirectional relationship
Insomnia and psychiatric illness are so deeply intertwined that it is often impossible — and ultimately unhelpful — to try to determine which came first. The relationship is bidirectional and self-reinforcing in ways that make both conditions worse when either is left unaddressed.
Depression disrupts sleep architecture profoundly — reducing slow-wave sleep, shortening REM latency, causing early morning awakening, and producing the characteristic pattern of waking at 3 or 4 AM unable to return to sleep. But sleep disruption also precipitates and maintains depression — the neurobiological effects of chronic sleep deprivation on mood regulation, stress system functioning, and emotional processing are direct and measurable. Treating depression without addressing sleep typically produces incomplete response. Treating insomnia in the context of depression frequently accelerates recovery from both.
Anxiety disorders generate the hyperarousal and ruminative thinking that are the defining psychological features of insomnia. The worried mind that will not quiet at bedtime, the physiological arousal that prevents sleep onset, the anticipatory anxiety about the approaching night — these are the psychological signature of anxiety-driven insomnia, and they require treatment that addresses the anxiety directly alongside the sleep disturbance.
Bipolar disorder involves circadian rhythm dysregulation as a core feature, with sleep disruption — particularly decreased need for sleep — as one of the earliest and most reliable markers of mood episode onset. Sleep monitoring is a central component of bipolar disorder management at Wave, and sleep disruption in a bipolar patient is treated with clinical urgency.
PTSD produces the full spectrum of sleep disturbance — difficulty initiating sleep, frequent nighttime awakening, trauma-related nightmares, and the hyperarousal that makes rest feel impossible. Sleep disruption in PTSD is both a symptom of the disorder and a factor that maintains it by impairing the emotional processing and memory consolidation that recovery requires.
ADHD is associated with circadian rhythm delays, difficulty with sleep onset, and inconsistent sleep-wake schedules that compound the attentional and executive function impairments of the condition itself. Stimulant medications used to treat ADHD carry their own sleep disruption risks that require active monitoring and management.
Our psychiatrists assess sleep thoroughly in every initial evaluation — not as an afterthought but as a clinically central dimension of the psychiatric picture. For many patients, the sleep history reveals important diagnostic and treatment information that shapes the entire approach to care.
Our approach to insomnia treatment
Wave's approach to insomnia is comprehensive and individualized, beginning with a thorough assessment that establishes the type, duration, and severity of the sleep disturbance, identifies the predisposing, precipitating, and perpetuating factors driving it, screens for underlying psychiatric and medical contributors, and determines whether any of the behavioral patterns maintaining the insomnia are amenable to structured intervention.
Cognitive-Behavioral Therapy for Insomnia
CBT-I is the first-line treatment for chronic insomnia — recommended ahead of pharmacotherapy by sleep medicine guidelines, primary care guidelines, and psychiatric guidelines alike — and it has the most durable evidence base of any insomnia intervention. Unlike sleep medications, which produce their effects only while being taken, CBT-I produces changes in the behavioral and cognitive patterns that perpetuate insomnia, and its benefits persist after treatment ends.
CBT-I is a structured, time-limited intervention — typically six to eight sessions — that combines several components. Sleep restriction therapy consolidates fragmented, inefficient sleep by temporarily limiting time in bed to match actual sleep time, rebuilding sleep pressure and improving sleep continuity before gradually extending the sleep window. Stimulus control reestablishes the association between the bed and sleep — and only sleep — by restricting activities in bed and regularizing sleep-wake timing. Cognitive restructuring addresses the unhelpful beliefs and catastrophic thinking about sleep that amplify arousal and perpetuate the insomnia cycle. Sleep hygiene education addresses modifiable behavioral factors — caffeine, alcohol, light exposure, exercise timing, and the sleep environment — that contribute to sleep disruption.
CBT-I requires engagement and behavioral commitment from the patient. The sleep restriction component, in particular, can produce short-term sleep deprivation before improvement occurs — and patients who understand why the treatment works, and what to expect, are far more likely to persist through that phase and achieve durable results. Our psychiatrists explain the rationale for every component of CBT-I clearly, because informed patients are better patients.
Medication management
Sleep medications have a meaningful but circumscribed role in insomnia treatment. They are most useful for acute insomnia, as a short-term bridge during a period of acute stress or difficulty, and as an adjunct during the early phases of CBT-I when sleep deprivation is most acute. They are not a long-term solution for chronic insomnia and do not produce the durable improvements that CBT-I achieves.
Our psychiatrists prescribe the full range of evidence-based sleep medications when clinically indicated — including low-dose doxepin, trazodone, mirtazapine, ramelteon, and the orexin receptor antagonists suvorexant and lemborexant — with careful attention to the specific sleep complaint, the patient's psychiatric and medical history, potential drug interactions, and the risk profiles of different agents.
Benzodiazepines and Z-drugs — zolpidem, eszopiclone, zaleplon — are effective for sleep onset and maintenance but carry well-established risks of dependence, tolerance, rebound insomnia upon discontinuation, cognitive side effects, and fall risk in older adults. Our psychiatrists prescribe them judiciously, for time-limited indications, with explicit discussion of their limitations and risks, and with a clear plan for tapering. They are not a first-line or long-term treatment for chronic insomnia at Wave.
We are also attentive to the sleep effects of the psychiatric medications our patients are taking for other conditions — both the sleep-disrupting effects of stimulants, SSRIs, and SNRIs, and the sedating effects of medications like quetiapine, mirtazapine, and trazodone that are sometimes prescribed with sleep improvement as a secondary goal. Optimizing the psychiatric medication regimen with attention to sleep timing and side effect profiles is a routine component of insomnia management at Wave.
Integrative approaches
Several integrative interventions have meaningful evidence in insomnia management and are discussed as part of comprehensive treatment planning at Wave.
Melatonin has a genuine but limited and frequently misapplied evidence base in insomnia. Its primary clinical utility is for circadian rhythm phase disorders — delayed sleep phase, jet lag, shift work — rather than for sleep maintenance insomnia, where its evidence is considerably weaker. Dose also matters — the pharmacological doses commonly available in US supplements are substantially higher than the physiological doses shown to be effective in research, and higher doses are not more effective and may be counterproductive. Our psychiatrists discuss melatonin with the clinical specificity it deserves rather than defaulting to it as a benign recommendation.
Magnesium glycinate has some evidence as a mild sleep aid and is a low-risk intervention with a favorable side effect profile. It is one of the few supplements our psychiatrists recommend in the context of insomnia when clinically appropriate.
Light exposure timing — morning bright light exposure to anchor the circadian clock and avoidance of blue-spectrum light in the evening — has meaningful evidence for circadian regulation and is discussed as a practical behavioral intervention for patients with circadian phase delays contributing to their insomnia.
Exercise has bidirectional effects on sleep — regular aerobic exercise is associated with improved sleep quality and reduced insomnia severity, while vigorous exercise close to bedtime can be activating and delay sleep onset in susceptible individuals. Timing and type of exercise are discussed in the context of each patient's specific sleep complaint.
Caffeine pharmacokinetics warrant explicit attention. Caffeine has a half-life of approximately five to seven hours in most adults — meaning that a cup of coffee at 2 PM still has half its caffeine concentration in the bloodstream at 7 or 8 PM. Many patients with insomnia are consuming caffeine in the afternoon and early evening without recognizing its contribution to their sleep difficulties. This is a simple, modifiable factor that our psychiatrists address directly.
Alcohol is a particularly important topic in insomnia. Alcohol is commonly used as a sleep aid — it reduces sleep onset latency and produces initial sedation — but it significantly disrupts sleep architecture in the second half of the night, suppressing REM sleep, increasing sleep fragmentation, and producing early morning awakening. Patients who rely on alcohol to fall asleep frequently experience the worst of both worlds — impaired sleep quality alongside the behavioral pattern of alcohol dependence on sleep. Our psychiatrists address alcohol's role in sleep disruption directly and without judgment as a routine component of insomnia evaluation.
When insomnia requires further evaluation
Some patients presenting with insomnia have underlying conditions that require evaluation beyond what a psychiatric assessment provides. Obstructive sleep apnea — characterized by repeated partial or complete upper airway obstruction during sleep, producing fragmented sleep, oxygen desaturation, and daytime sleepiness — is one of the most common and most underdiagnosed medical causes of non-restorative sleep and fatigue. It can closely mimic insomnia and is frequently missed when not specifically screened for. Our psychiatrists screen for sleep apnea as a routine component of every insomnia evaluation and refer for sleep study when indicated.
Restless legs syndrome, periodic limb movement disorder, circadian rhythm sleep-wake disorders, and narcolepsy are among the other sleep disorders that can contribute to or mimic insomnia and that may warrant referral to a sleep medicine specialist for formal polysomnographic evaluation. Our psychiatrists maintain referral relationships with sleep medicine colleagues and refer appropriately when the clinical picture suggests a primary sleep disorder beyond the scope of outpatient psychiatric management.
Insurance and fees
Wave Psychiatric Group accepts Aetna, Optum / UnitedHealthcare Behavioral Health, Meritain Health, Oxford Health Plans, ComPsych, UC SHIP, and others for diagnostic assessment appointments. Self-pay rates are also available.
Call us at 323-688-6380 or complete our intake form and our team will verify your benefits before your first appointment.
Frequently Asked Questions
What is the difference between insomnia and just being a poor sleeper?
Insomnia as a clinical condition requires both subjective sleep difficulty and meaningful daytime impairment occurring with sufficient frequency and duration to warrant treatment. Many people sleep less than recommended amounts without experiencing significant daytime dysfunction — this is not clinical insomnia. The clinical threshold is not primarily about hours of sleep but about the combination of subjective sleep dissatisfaction and its functional consequences. If your sleep difficulties are affecting your mood, energy, cognitive function, work performance, or quality of life in meaningful ways, a clinical evaluation is appropriate.
Is CBT-I really more effective than sleep medication?
Yes — and this is one of the most well-established findings in sleep medicine research. Multiple randomized controlled trials and meta-analyses have demonstrated that CBT-I produces comparable or superior improvements in sleep onset, sleep efficiency, and wake after sleep onset relative to pharmacotherapy, with significantly more durable outcomes. Sleep medications produce improvement only while they are being taken and are associated with rebound insomnia upon discontinuation. CBT-I produces changes in the underlying behavioral and cognitive mechanisms that perpetuate insomnia and its benefits persist after treatment ends. For chronic insomnia, CBT-I is the treatment of first choice, and medication is best understood as a short-term adjunct rather than a long-term solution.
Can psychiatric medication cause insomnia?
Yes. Several commonly prescribed psychiatric medications have sleep-disrupting effects that warrant attention. SSRIs and SNRIs can delay sleep onset, reduce REM sleep, and increase nighttime awakenings — effects that are most prominent early in treatment and often diminish over time but persist in some patients. Stimulant medications for ADHD can significantly delay sleep onset when taken too late in the day. Bupropion is activating and can disrupt sleep in susceptible individuals. Our psychiatrists review medication timing and side effect profiles as a routine component of insomnia evaluation and adjust regimens when medication timing or choice is contributing to sleep disruption.
I have been taking sleep medication for years. Can I stop?
Discontinuing long-term sleep medications — particularly benzodiazepines and Z-drugs — requires a gradual, supervised tapering process. Abrupt discontinuation carries risks of rebound insomnia, withdrawal symptoms, and in the case of benzodiazepines, potentially serious physiological withdrawal. Our psychiatrists regularly help patients taper off long-term sleep medications in a controlled, supported way — typically in parallel with CBT-I, which builds the behavioral foundation needed to sleep without medication before the medication is removed. This is one of the clinical scenarios where the integration of medication management and psychotherapy within the same clinical relationship is particularly valuable.
Could my insomnia be caused by sleep apnea?
Possibly — and this is worth evaluating carefully. Obstructive sleep apnea is common, frequently undiagnosed, and produces non-restorative sleep, nighttime awakening, and daytime fatigue that can closely resemble insomnia. Risk factors include snoring, witnessed apneas during sleep, obesity, male sex, and certain anatomical features — but sleep apnea occurs in individuals without classic risk factors as well. Our psychiatrists screen for sleep apnea at every insomnia evaluation and refer for sleep study when the clinical picture warrants it.
Does insomnia require medication?
Not necessarily, and often not as a first step. CBT-I is the first-line treatment for chronic insomnia and is effective without medication for most patients who engage with it fully. Medication is most useful as a short-term bridge, during acute stress or difficulty, or as a short-term adjunct during the early phases of CBT-I. For patients with comorbid psychiatric conditions — depression, anxiety, bipolar disorder — treating the underlying condition is often the most important intervention for the insomnia. Our psychiatrists develop individualized treatment plans that reflect the specific nature of each patient's sleep difficulty and their broader psychiatric picture.